非补偿性心力衰竭的门诊治疗:系统性审查和研究水平的元分析
Jameela Bahar1, Amna Rahman1, Grace W Y Wong2
1Department of Cardiology, Lancashire Cardiac Centre, Blackpool, UK.
ESC heart failure
|July 16, 2024
概括
与住院护理相比,急性不补偿性心力衰竭 (ADHF) 的门诊管理 (OPM) 可能会减少30天的死亡率和住院治疗. 然而,需要进一步的大规模随机对照试验来证实ADHF患者的这些发现.
科学领域:
- 心脏病学 心脏病学
- 心脏衰竭管理的管理
- 医疗保健服务研究 医疗服务研究
背景情况:
- 急性不补偿性心力衰竭 (ADHF) 通常需要住院接受静脉注射 (IV) 利尿剂治疗.
- 越来越多的人对在传统医院环境之外提供ADHF治疗感兴趣,例如在家中或在日托单位.
- 对ADHF的门诊治疗 (OPM) 的安全性和有效性在很大程度上仍未确立.
研究的目的:
- 系统地审查和元分析OPM对ADHF的短期安全性和有效性.
- 为了比较OPM与传统的住院管理 (IPM) 关于30天死亡率和住院率.
主要方法:
- 系统的文献审查和对ADHF的OPM研究的元分析.
- 包括29项研究与7683名患者;五项研究直接比较OPM与IPM (1303 OPM对比2047 IPM).
- 终点包括30天全因死亡率和30天全因住院;分析使用RevMan 5.4软件.
主要成果:
- 五项比较研究的综合分析显示,OPM的30天死亡率较低 (9.3%),而不是IPM (15.6%) [或0.29].
- 与IPM (22.0%) [或0.73]相比,OPM与30天住院率 (16.8%) 的显著降低有关.
- 两项随机对照试验 (RCT) 在OPM和IPM之间30天死亡率或住院没有显著差异.
结论:
- 观察性研究表明,ADHF的OPM与减少30天住院和死亡率有关.
- 这两个小型RCT没有证明这些好处,突出了研究设计或样本大小的潜在局限性.
- 一个大规模的多中心RCT是必不可少的,以最终确认OPM在ADHF管理中的安全性和有效性.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
418
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
418
Heart Failure Drugs: Diuretics
361
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
361
Heart Failure Drugs: β-Blockers
336
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: Inotropic Agents
563
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
563
Exercise and Cardiovascular Response
771
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
771


